125 related articles for article (PubMed ID: 38537982)
1. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Limb Function and QOL in Elderly Patients With Malignant Bone Tumor/Soft Tissue Sarcoma.
Kinoshita H; Kinoshita S; Hagiwara Y; Kamoda H; Ohtori S; Yonemoto T
Anticancer Res; 2023 Jul; 43(7):3273-3279. PubMed ID: 37352003
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
[TBL] [Abstract][Full Text] [Related]
4. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma.
Takenaka S; Araki N; Outani H; Hamada KI; Yoshikawa H; Kamada T; Imai R
Cancer; 2020 Sep; 126(18):4188-4196. PubMed ID: 32658315
[TBL] [Abstract][Full Text] [Related]
5. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
[TBL] [Abstract][Full Text] [Related]
6. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
[TBL] [Abstract][Full Text] [Related]
7. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
[TBL] [Abstract][Full Text] [Related]
8. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
[TBL] [Abstract][Full Text] [Related]
9. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature.
Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300
[TBL] [Abstract][Full Text] [Related]
10. Total spondylectomy following carbon ion radiotherapy to treat chordoma of the mobile spine.
Matsumoto T; Imagama S; Ito Z; Imai R; Kamada T; Shimoyama Y; Matsuyama Y; Ishiguro N
Bone Joint J; 2013 Oct; 95-B(10):1392-5. PubMed ID: 24078538
[TBL] [Abstract][Full Text] [Related]
11. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
[TBL] [Abstract][Full Text] [Related]
12. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.
Aoki S; Koto M; Ikawa H; Imai R; Tokuhiko O; Shinoto M; Takiyama H; Yamada S; Tsuji H
Head Neck; 2022 Oct; 44(10):2162-2170. PubMed ID: 35734902
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities.
Takakusagi Y; Serizawa I; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Katoh H; Hiruma T; Kamada T
Anticancer Res; 2022 Jul; 42(7):3701-3706. PubMed ID: 35790269
[TBL] [Abstract][Full Text] [Related]
16. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
[TBL] [Abstract][Full Text] [Related]
17. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
[No Abstract] [Full Text] [Related]
18. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
[TBL] [Abstract][Full Text] [Related]
19. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
[TBL] [Abstract][Full Text] [Related]
20. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
